Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06797856 · ClinicalTrials.gov registry record
Measurement of Refractive Error in Pseudophakic Eyes Using an Autorefractor and a Wavefront Aberrometer
A clinical trial, sponsored by Johnson & Johnson Surgical Vision.
- Completed
- Registry status
- 46
- Enrollment target
NCT06797856 is a clinical trial that has completed, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 46 participants.
The verdict
NCT06797856 has completed, sponsored by Johnson & Johnson Surgical Vision.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
Prospective, single-site, non-interventional, technician masked, randomized (instrument and examiner testing sequences), controlled, bilateral, parallel-group study.
Interventions
- DIAGNOSTIC_TEST Refractive Error
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2025-02-17 |
| Est. Completion | 2025-07-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06797856
The ClinicalTrials.gov registry entry for NCT06797856 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Surgical Vision, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Refractive Error is the first listed.
NCT06797856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06797856 about?
NCT06797856 is a clinical study titled "Measurement of Refractive Error in Pseudophakic Eyes Using an Autorefractor and a Wavefront Aberrometer". Prospective, single-site, non-interventional, technician masked, randomized (instrument and examiner testing sequences), controlled, bilateral, parallel-group study.
What is the current status of trial NCT06797856?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2025-02-17. Estimated completion is 2025-07-09.
What interventions are being tested in trial NCT06797856?
The interventions under investigation include: Refractive Error (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06797856?
This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.